RadNet, Inc. (RDNT) Financials

RDNT Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 4.2 billion 2.8 billion
March 31, 2026 3.9 billion 2.5 billion
Dec. 31, 2025 3.8 billion 2.4 billion
Sept. 30, 2025 3.7 billion 2.4 billion

RDNT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 157.7 million 10.5 million
March 31, 2026 22.3 million 31.4 million
Dec. 31, 2025 -230.9 million 8.3 million
Sept. 30, 2025 -7.6 million 9.0 million

RDNT Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 29.0 million
March 31, 2026 -33.5 million
Dec. 31, 2025 9.9 million
Sept. 30, 2025 13.9 million

RDNT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 726.3 million 1.3 billion 850.2 million
March 31, 2026 455.3 million 1.1 billion 847.9 million
Dec. 31, 2025 767.2 million 1.1 billion 768.9 million
Sept. 30, 2025 804.7 million 1.1 billion 751.3 million

RDNT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 78.7 million
March 31, 2026 77.1 million
Dec. 31, 2025 75.2 million
Sept. 30, 2025 74.7 million

RDNT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 69.9 million - - -
March 31, 2026 69.9 million - - -
Dec. 31, 2025 315.0 million 3.6 million - -
Sept. 30, 2025 60.4 million 3.6 million - -

RDNT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 622.7 million 534.6 million
March 31, 2026 575.6 million 592.0 million
Dec. 31, 2025 547.7 million 471.8 million
Sept. 30, 2025 522.9 million 450.4 million

RDNT Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RDNT

Price: $73.71

52 week price:
50.82
85.84

Payout Ratio Range:
-40.08%
82.75%

Earnings Per Share: -0.26 USD

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 93400

Ebitda: 32.2 million

Market Capitalization: 6.0 billion

Links: